NCT02184559

Brief Summary

The purpose of the multimodal postoperative analgesia is to improve the quality of analgesia and reduce side effects of morphine (nausea, vomiting, sedation, urinary retention, respiratory depression ...). In the case of caesarean sections, the quality of analgesia allows one hand to improve the mother-child relationship and the quality of breastfeeding, the other to reduce the risk of postpartum depression and chronic pain . Two methods of administration of local anesthetics have been proven effective for analgesia of the abdominal wall under umbilical: The Transversus Abdominal Block Plan (TAP Block) and infiltration of the scar continues operating. The TAP block was performed under ultrasound guidance by the anesthesiologist after the intervention in a single injection of local anesthetic in the abdominal wall and has a period of limited and variable. The infiltration continues catheter is placed by the surgeon before closing the wound and allows the infusion of local anesthetics for 48 hours. The purpose of this study was to compare morphine consumption between both techniques, and the quality of analgesia and side effects of morphine

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Feb 2012

Typical duration for phase_3

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2012

Completed
2.4 years until next milestone

First Submitted

Initial submission to the registry

June 25, 2014

Completed
14 days until next milestone

First Posted

Study publicly available on registry

July 9, 2014

Completed
23 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2014

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2015

Completed
Last Updated

July 9, 2014

Status Verified

July 1, 2014

Enrollment Period

2.5 years

First QC Date

June 25, 2014

Last Update Submit

July 8, 2014

Conditions

Outcome Measures

Primary Outcomes (1)

  • Consumption morphinize

    the cosumption of morphinize is collected since the first hours of comsumption to the 48 th hours

    48 hours

Secondary Outcomes (1)

  • Analgesic efficiency

    48 hours

Study Arms (2)

TAP block

EXPERIMENTAL
Drug: Ropivacaine

infiltration continues

ACTIVE COMPARATOR
Device: The infiltration continues catheter

Interventions

comparaison of two methods of administration for analgesia using the same drugs in the same indication after Caesarean section

TAP block
infiltration continues

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Woman whose age is 18 years
  • Encircled Woman requiring a scheduled(programmed) caesarian, under spinal anesthesia or died combined(organized) spinal anesthesia
  • Woman ASA I and II
  • Term = 37 LIMITED COMPANIES
  • Woman primipare or not
  • Woman having signed an informed consent writes and making a commitment to respect the instructions of the protocol

You may not qualify if:

  • Minor Woman
  • Woman presenting a contraindication to the anesthesia périmédullaire: constitutional or acquired disorders(confusions) of the haemostasis, the allergy in the local anesthetics, the infectious context (hypertherm \> 38.5 ° C)
  • Woman presenting an intolerance or an allergy known about the morphine in the paracetamol or in AIN
  • The surgical histories of laparotomy
  • The morbid obesity BMI \> 35
  • Dysgravidies
  • Woman not being affiliated to the national insurance scheme
  • Woman under legal protection
  • Woman not having signed an informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assistance Publique Hopitaux de Marseille

Marseille, 13354, France

RECRUITING

MeSH Terms

Interventions

Ropivacaine

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Study Officials

  • loic MONDOLONI

    Assistance Publique Hopitaux De Marseille

    STUDY DIRECTOR

Central Study Contacts

aurelie BOURGOIN

CONTACT

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 25, 2014

First Posted

July 9, 2014

Study Start

February 1, 2012

Primary Completion

August 1, 2014

Study Completion

February 1, 2015

Last Updated

July 9, 2014

Record last verified: 2014-07

Locations